Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

30

Revenue 2017

Botox/Neuromodulator

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Botox/Neuromodulator was produced by Allergan.

Pharma funding and M&A in 2020

Pharma funding and M&A in 2020

a cool $63bn (which was also notable for putting the world’s best-selling drug Humira under the same roof as Botox).

Lundbeck gets US approval for migraine drug at heart of Alder takeover

Lundbeck gets US approval for migraine drug at heart of Alder takeover specialists aren’t rushing to switch wholesale from other migraine preventative therapies like Allergan’s Botox.

20 for 2020 – Five pharma companies to watch

20 for 2020 – Five pharma companies to watch year. Botox is facing tougher competition in the market from new migraine drugs as well as rivals in its medical aesthetics indications. ... The latter is still low level, however, and biosimilars to Botox are thought to be some years off the market.

Revenue growth at Ipsen numbs pain of palovarotene calamity

Revenue growth at Ipsen numbs pain of palovarotene calamity as Dysport (abobotulinumtoxinA), a rival to Allergan’s big-selling Botox brand.

Botox strength bolsters Allergan ahead of AbbVie takeover

Botox strength bolsters Allergan ahead of AbbVie takeover The US specialised therapeutics business – which include Botox – posted just 0.7% growth in the quarter to $1.82bn as medical aesthetics products Juvederm and Restasis posted sales declines. ... AbbVie has already announced plans to spin off the

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
AMICULUM

AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >300 healthcare communications professionals,...

Latest intelligence

Pharmaceutical Marketing Strategies For The Digital Age
In the digital age, a strong digital marketing strategy is crucial for businesses, especially in the highly competitive and complex pharmaceutical industry. There are key trends shaping pharmaceutical marketing, such...
The challenges of identifying rare diseases
With increased awareness and improved diagnosis, more rare diseases are being recognised and this number is likely to increase in the coming years...
5 ways we’re enhancing our services to support our clients in 2023
Fishawack Health CEO Jon Koch explains the new platforms, tools, and services we’re elevating to drive innovation for our clients in 2023....